Candidates for peptide receptor radiotherapy today and in the future.
about
Medical management of metastatic medullary thyroid cancerIn-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphomaPepBank--a database of peptides based on sequence text mining and public peptide data sources.Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?Bombesin receptor-mediated imaging and cytotoxicity: review and current statusProgress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potentialSynthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.In vivo molecular targeted radiotherapy.Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?Targeting prostate cancer with radiolabelled bombesins.[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical studyThree-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerSynthesis and biological evaluation of a novel pentagastrin-toxin conjugate designed for a targeted prodrug mono-therapy of cancer.Radionuclide carriers for targeting of cancer.68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide.A high-affinity near-infrared fluorescent probe to target bombesin receptors.Radiolabeled peptides: valuable tools for the detection and treatment of cancerRing size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Q27005897-52B94507-7106-4665-8B84-8B8FCA544B07Q27305229-6874E5A4-EA7F-4A03-99CC-332D5C9F19A3Q30444431-0B46EDE3-292F-4057-AEC6-54BC43E2902BQ30476895-60ADEB23-3976-4ED8-96D4-96F7E61846A5Q30487910-B21385EC-76D3-4CEA-8128-755579A85060Q33455875-752CC97A-B301-43B5-8E0E-EC5FDA8DD4C0Q34083332-EB560BE2-0D0D-4217-AF1F-4F84A82232F3Q34256413-E168C2E2-040E-4C54-BB04-ACB066795179Q34335207-E2F19D1F-0D2C-4C2F-B26A-2BDC284CBFB5Q34684387-F4859498-FD6A-4B1A-BDE9-3E30E1A17922Q34712671-D9A6F28A-1656-47FD-829F-8C0899A86451Q34777749-0E9EF244-7EDF-4364-B7D9-FA2B01D0F94BQ34991297-79953B3D-33E4-45FB-BC2D-FEEF67892905Q35015049-8E131A97-09E3-4F24-87F5-672CD66EE987Q35214872-BFE66A0A-6F43-44E3-A5D3-C3E02823BB0FQ36125639-8EBD61DA-BF7E-4157-A03D-7A11DA4638C0Q36300599-40356B99-28F5-4500-92BD-8DC69D3067C8Q36508615-D56BD5CE-3FD4-4970-AF99-A81B49D0BFA8Q36834005-730E168D-0839-463B-A138-4FCA816911A7Q37083440-A1B7BD07-F873-4095-B4DE-D85C706AAC63Q37237705-181A5916-C8F1-455E-AD23-42B82F89E42AQ37592067-C6DCF5F5-DD6D-4DA7-A941-8CEF11AFAC78Q38739396-6F29E19D-7588-42E7-B3AB-9EFDD8809CC1Q39017820-16A1A312-1A90-42DD-8221-0C342EF9BE70Q39596344-46EDA5B6-6C9D-4FDA-9D98-01FEBEA6D7EAQ42666778-8BCEE129-A83F-4A69-BE0A-162CB2CCC395Q52715248-EAF4998F-9B5F-4BBA-84BF-92B80A0F5268Q55709770-33ECAD77-E70A-4E59-B1F1-12F167174631
P2860
Candidates for peptide receptor radiotherapy today and in the future.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Candidates for peptide receptor radiotherapy today and in the future.
@ast
Candidates for peptide receptor radiotherapy today and in the future.
@en
type
label
Candidates for peptide receptor radiotherapy today and in the future.
@ast
Candidates for peptide receptor radiotherapy today and in the future.
@en
prefLabel
Candidates for peptide receptor radiotherapy today and in the future.
@ast
Candidates for peptide receptor radiotherapy today and in the future.
@en
P2093
P1476
Candidates for peptide receptor radiotherapy today and in the future
@en
P2093
Eric P Krenning
Helmut R Mäcke
Jean Claude Reubi
P304
P407
P478
46 Suppl 1
P577
2005-01-01T00:00:00Z